Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mocroft

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|September 18, 2001
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort studyE Martinez, A Mocroft, M A García-Viejo, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1997
CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patientsA Mocroft, M Bofill, M Lipman, et al.
HIV Medicine|July 31, 2019
Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls: the Copenhagen Comorbidity in HIV Infection (COCOMO) studyN Petersen, A D Knudsen, A Mocroft, et al.
HIV Medicine|July 29, 2015
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D studyA C Achhra, A Mocroft, P Reiss, et al.
AIDS (London, England)|July 1, 1996
Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patientsM Bofill, A Mocroft, M Lipman, et al.
Ebiomedicine|August 20, 2015
Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus InfectionsI P Lodding, H Sengeløv, C da Cunha-Bang, et al.
AIDS (London, England)|June 27, 2001
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyE Martínez, J L Blanco, J A Arnaiz, et al.
HIV Medicine|June 22, 2010
Late presentation of HIV infection: a consensus definitionA Antinori, T Coenen, D Costagiola, et al.
HIV Medicine|October 23, 2015
European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome StatementsC Mussini, A Antinori, S Bhagani, et al.
The Journal of Infection|October 25, 2017
Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV studyA M W Efsen, A Schultze, R F Miller, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|September 18, 2001
Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort studyE Martinez, A Mocroft, M A García-Viejo, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1997
CD8+,CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patientsA Mocroft, M Bofill, M Lipman, et al.
HIV Medicine|July 31, 2019
Prevalence of impaired renal function in virologically suppressed people living with HIV compared with controls: the Copenhagen Comorbidity in HIV Infection (COCOMO) studyN Petersen, A D Knudsen, A Mocroft, et al.
HIV Medicine|July 29, 2015
Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D studyA C Achhra, A Mocroft, P Reiss, et al.
AIDS (London, England)|July 1, 1996
Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patientsM Bofill, A Mocroft, M Lipman, et al.
Ebiomedicine|August 20, 2015
Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus InfectionsI P Lodding, H Sengeløv, C da Cunha-Bang, et al.
AIDS (London, England)|June 27, 2001
Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapyE Martínez, J L Blanco, J A Arnaiz, et al.
HIV Medicine|June 22, 2010
Late presentation of HIV infection: a consensus definitionA Antinori, T Coenen, D Costagiola, et al.
HIV Medicine|October 23, 2015
European AIDS Clinical Society Standard of Care meeting on HIV and related coinfections: The Rome StatementsC Mussini, A Antinori, S Bhagani, et al.
The Journal of Infection|October 25, 2017
Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV studyA M W Efsen, A Schultze, R F Miller, et al.
Pageof 12